Beclomin® HFA Inhaler

৳ 320.96

Generic: Beclometasone Dipropionate
Strength: 250 mcg/puff
Manufacturer: Square Pharmaceuticals Ltd.

Description

About This Item

Dosage & Administration:
Beclometasone dipropionate Inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled beclometasone dipropionate appropriate to the severity of their disease. The dose may then be adjusted until control is achieved, or reduced to the minimum effective dose according to individual response.

Adults (including the elderly): The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may need to increase to 600 to 800 micrograms per day which may then be reduced when the patient’s asthma has stabilized. The total daily dose may be administered as two, three, or four divided doses

Children: 50 to 100 micrograms should be given two, three, or four times daily in accordance with the response. Alternatively, 100 micrograms or 200 micrograms twice daily should be given. The usual starting dose is 100 micrograms twice daily

Beclometasone 250 Inhaler is not recommended for children.

There is no need to increase the dose in patients with hepatic or renal impairment.

Beclometasone 250 HFA Inhaler: The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may need to increase to 600 to 800 micrograms per day which may then be reduced when the patient’s asthma has stabilized. The total daily dose may be administered as two, three, or four divided doses

Preparation:
Each Inhaler delivers 200 puffs.

Indication:
Beclometasone 250 HFA Inhaler is indicated in the prophylactic management of mild, moderate, or severe asthma in adults or children.
Beclometasone dipropionate given by inhalation offers preventative treatment for asthma. It provides effective anti-inflammatory action in the lungs with a
lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.
Mild asthma :
Patients requiring symptomatic bronchodilator asthma medication on a regular basis.
Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy
or
bronchodilator alone.
Severe asthma : Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms. Many patients who are dependent on systemic corticosteroids for adequate control of symptoms may be able to reduce significantly, or eliminate, their requirement for oral corticosteroids when they are transferred to high dose inhaled beclometasone dipropionate.

* চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Reviews

There are no reviews yet.

Be the first to review “Beclomin® HFA Inhaler”